ARCHIVES

FDA Vs. NCI: Nothing Has Changed; Chabner “Frustrated” By Flutamide Delay

This article is from The Cancer Letter archive.

Vol. 14 No. 41 | October 21, 1988

Download PDF Visit The Full Archive

Related Articles

News In Brief: ACS Abandons Plan To Cut Local, Unit Boards Of Directors

October 9, 1998

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

December 28, 2012

Next Bypass Budget: Slim, Trim, Modest

September 15, 1995

NCI To Recompete Drug Discovery Groups In 2003 As Program Nears Its 20th Year

November 29, 2002

Study: Vismodegib Effective Where Surgery is Inappropriate

June 24, 2011

Cancer Clinical Trials Approved By NCI Last Month Are Listed

November 29, 2002